Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jun;63(6):2347–2351. doi: 10.1128/iai.63.6.2347-2351.1995

Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific.

L B Gilleland 1, H E Gilleland Jr 1
PMCID: PMC173309  PMID: 7539410

Abstract

Peptide 9 (TDAYNQKLSERRAN) and peptide 10 (NATAEGRAINRRVE) represent surface-exposed epitopes of outer membrane protein F of Pseudomonas aeruginosa. Rats immunized with four intramuscular inoculations on days 0, 14, 28, and 42 with either peptide 9 or peptide 10 conjugated to keyhole limpet hemocyanin were afforded protection against pulmonary lesions when examined 7 days subsequent to challenge (day 56) via intratracheal inoculation of P. aeruginosa-containing agar beads. Peptide 9 shares considerable homology with other OmpA-related outer membrane proteins in various bacteria, whereas peptide 10 displays little homology with these other proteins. Antisera directed to peptide 9 reacted weakly with cell envelope proteins from the various other OmpA-associated bacteria upon immunoblot analysis. However, antisera directed to peptide 10 reacted only with Neisseria gonorrhoeae cell envelope proteins upon immunoblot analysis. Antisera to both peptides 9 and 10 reacted at minimal titers with whole cells of the various other bacteria in a whole-cell enzyme-linked immunosorbent assay (ELISA) but antisera to each of the peptides reacted at high titers when various strains of P. aeruginosa were used as the ELISA antigen. Antibodies to peptides 9 and 10 were protective, reactive to all strain of P. aeruginosa tested except for a protein F-deficient mutant, and functionally specific against pseudomonads.

Full Text

The Full Text of this article is available as a PDF (384.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Mot R., Vanderleyden J. The C-terminal sequence conservation between OmpA-related outer membrane proteins and MotB suggests a common function in both gram-positive and gram-negative bacteria, possibly in the interaction of these domains with peptidoglycan. Mol Microbiol. 1994 Apr;12(2):333–334. doi: 10.1111/j.1365-2958.1994.tb01021.x. [DOI] [PubMed] [Google Scholar]
  2. Fox C. W., Campbell G. D., Jr, Anderson W. M., Zavecz J. H., Gilleland L. B., Gilleland H. E., Jr Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa. Chest. 1994 May;105(5):1545–1550. doi: 10.1378/chest.105.5.1545. [DOI] [PubMed] [Google Scholar]
  3. Gentry-Weeks C. R., Hultsch A. L., Kelly S. M., Keith J. M., Curtiss R., 3rd Cloning and sequencing of a gene encoding a 21-kilodalton outer membrane protein from Bordetella avium and expression of the gene in Salmonella typhimurium. J Bacteriol. 1992 Dec;174(23):7729–7742. doi: 10.1128/jb.174.23.7729-7742.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gilleland H. E., Gilleland L. B., Fowler M. R. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model. J Med Microbiol. 1993 Feb;38(2):79–86. doi: 10.1099/00222615-38-2-79. [DOI] [PubMed] [Google Scholar]
  5. Gilleland H. E., Jr, Gilleland L. B., Matthews-Greer J. M. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect Immun. 1988 May;56(5):1017–1022. doi: 10.1128/iai.56.5.1017-1022.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gilleland H. E., Jr, Lyle R. D. Chemical alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates. J Bacteriol. 1979 Jun;138(3):839–845. doi: 10.1128/jb.138.3.839-845.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gilleland H. E., Jr, Parker M. G., Matthews J. M., Berg R. D. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun. 1984 Apr;44(1):49–54. doi: 10.1128/iai.44.1.49-54.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gotoh N., Wakebe H., Yoshihara E., Nakae T., Nishino T. Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. J Bacteriol. 1989 Feb;171(2):983–990. doi: 10.1128/jb.171.2.983-990.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hancock R. E., Mutharia L. M., Chan L., Darveau R. P., Speert D. P., Pier G. B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun. 1983 Oct;42(1):170–177. doi: 10.1128/iai.42.1.170-177.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hardham J. M., Stamm L. V. Identification and characterization of the Treponema pallidum tpn50 gene, an ompA homolog. Infect Immun. 1994 Mar;62(3):1015–1025. doi: 10.1128/iai.62.3.1015-1025.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hughes E. E., Gilleland L. B., Gilleland H. E., Jr Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Infect Immun. 1992 Sep;60(9):3497–3503. doi: 10.1128/iai.60.9.3497-3503.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Klinger J. D., Cash H. A., Wood R. E., Miler J. J. Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats. Infect Immun. 1983 Mar;39(3):1377–1384. doi: 10.1128/iai.39.3.1377-1384.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Matthews-Greer J. M., Gilleland H. E., Jr Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J Infect Dis. 1987 Jun;155(6):1282–1291. doi: 10.1093/infdis/155.6.1282. [DOI] [PubMed] [Google Scholar]
  14. Pier G. B., Desjardins D., Aguilar T., Barnard M., Speert D. P. Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol. 1986 Aug;24(2):189–196. doi: 10.1128/jcm.24.2.189-196.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ried G., Koebnik R., Hindennach I., Mutschler B., Henning U. Membrane topology and assembly of the outer membrane protein OmpA of Escherichia coli K12. Mol Gen Genet. 1994 Apr;243(2):127–135. doi: 10.1007/BF00280309. [DOI] [PubMed] [Google Scholar]
  16. Stinnett J. D., Gilleland H. E., Jr, Eagon R. G. Proteins released from cell envelopes of Pseudomonas aeruginosa on exposure to ethylenediaminetetraacetate: comparison with dimethylformamide-extractable proteins. J Bacteriol. 1973 Apr;114(1):399–407. doi: 10.1128/jb.114.1.399-407.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. de Mot R., Vanderleyden J. A conserved surface-exposed domain in major outer membrane proteins of pathogenic Pseudomonas and Branhamella species shares sequence homology with the calcium-binding repeats of the eukaryotic extracellular matrix protein thrombospondin. Mol Microbiol. 1994 Jul;13(2):379–380. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES